30
Participants
Start Date
July 6, 2015
Primary Completion Date
June 7, 2022
Study Completion Date
June 7, 2022
Methylprednisolone
Methyprednisolone will be administered 1 to 3 pulses at a dose of 1000 milligram (mg) IV at the discretion of the investigator.
Prednisone
Prednisone will be administered orally at tapered dose (start at 1 milligrams per kilogram per day \[mg/kg/day\]) at the discretion of investigator given daily until participants are off the drug.
Rituximab
Rituximab will be administered at 375 milligrams per meter square (mg/m\^2) of body surface area given by IV infusion once weekly from Week 1 to 4.
Medanta-The Medicity, Gurgaon
Fortis Memorial Research Instititute, Gurgaon
MULJIBHAI PATEL UROLOGICAL HOSPITAL; Nephrology, Gujarat
Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute; Department of Rheumatologz, Mumbai
Jasleen Hospital, Nagpur
Yashoda Hospital, Hyderabad
St. John's Medical College Hospital; Rheumatology, Bangalore
Chanre Rheumatology and Immunology Center and Research, Bangalore
Apollo BGS Hospitals, Mysuru
Fortis Hospital, Noida
Hoffmann-La Roche
INDUSTRY